About VeraDermics
VeraDermics is a company based in San Antonio (United States) founded in 2020 by Kyle Ryder.. VeraDermics has raised $262.71 million across 5 funding rounds from investors including Marshall Wace, Citadel and Columbia Threadneedle Investments. VeraDermics offers products and services including VDPHL and Dermatology Pipeline. VeraDermics operates in a competitive market with competitors including Ironwood Pharma, scPharmaceuticals, Crossject, Valeritas and CeQur, among others.
- Headquarter San Antonio, United States
- Founders Kyle Ryder
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Veradermics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$262.71 M (USD)
in 5 rounds
-
Latest Funding Round
$150 M (USD), Series C
Oct 16, 2025
-
Investors
Marshall Wace
& 16 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VeraDermics
VeraDermics offers a comprehensive portfolio of products and services, including VDPHL and Dermatology Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Once-daily oral treatment for pattern hair loss.
Novel therapeutics for conditions like warts and atopic dermatitis.
Unlock access to complete
Funding Insights of VeraDermics
VeraDermics has successfully raised a total of $262.71M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $150 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $150.0M
-
First Round
First Round
(09 Oct 2020)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series C - VeraDermics | Valuation | SR One | |
| Dec, 2024 | Amount | Series B - VeraDermics | Valuation | Suvretta Capital Management | |
| May, 2023 | Amount | Series B - VeraDermics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in VeraDermics
VeraDermics has secured backing from 17 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Marshall Wace, Citadel and Columbia Threadneedle Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Early- to growth-stage startups are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
PhiFund Ventures is focused on early-stage life sciences investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VeraDermics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - VeraDermics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Veradermics Comparisons
Competitors of VeraDermics
VeraDermics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, scPharmaceuticals, Crossject, Valeritas and CeQur, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
|
| domain | founded_year | HQ Location |
Needle-free self-injectable drugs
|
|
| domain | founded_year | HQ Location |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| domain | founded_year | HQ Location |
Wearable insulin delivery patches are developed for mealtime dosing.
|
|
| domain | founded_year | HQ Location |
Developer of vaccines to treat cancer and infectious diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Veradermics
Frequently Asked Questions about VeraDermics
When was VeraDermics founded?
VeraDermics was founded in 2020.
Where is VeraDermics located?
VeraDermics is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Is VeraDermics a funded company?
VeraDermics is a funded company, having raised a total of $262.71M across 5 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Oct 09, 2020.
What does VeraDermics do?
VeraDermics was founded in 2020 and is based in San Antonio, United States. Operations focus on the biotechnology sector, where drug-delivery solutions for pediatric dermatological conditions, particularly warts, are developed. The proprietary WartPatch serves as a targeted platform for administering treatments to children, addressing common skin issues in this demographic. Activities emphasize safe and effective delivery mechanisms for young patients.
Who are the top competitors of VeraDermics?
VeraDermics's top competitors include Ironwood Pharma, scPharmaceuticals and Crossject.
What products or services does VeraDermics offer?
VeraDermics offers VDPHL and Dermatology Pipeline.
Who are VeraDermics's investors?
VeraDermics has 17 investors. Key investors include Marshall Wace, Citadel, Columbia Threadneedle Investments, Suvretta Capital Management, and Longitude Capital.